2022
Hepatic Metastases in Gastrointestinal Stromal Tumors: Oncologic Outcomes with Curative-Intent Hepatectomy, Resection of Treatment-Resistant Disease, and Tyrosine Kinase Inhibitor Therapy Alone
Sutton T, Walker B, Billingsley K, Sheppard B, Corless C, Heinrich M, Mayo S. Hepatic Metastases in Gastrointestinal Stromal Tumors: Oncologic Outcomes with Curative-Intent Hepatectomy, Resection of Treatment-Resistant Disease, and Tyrosine Kinase Inhibitor Therapy Alone. Hepato Pancreato Biliary 2022, 24: s90-s91. DOI: 10.1016/j.hpb.2022.05.170.Peer-Reviewed Original Research
2016
Aggressive approach to hepatic resection and adjuvant tyrosine kinase inhibitor therapy for metastatic gastrointestinal stroma tumors: Outcomes on survival
Pichardo E, Castillo A, Heinrich M, Billingsley K. Aggressive approach to hepatic resection and adjuvant tyrosine kinase inhibitor therapy for metastatic gastrointestinal stroma tumors: Outcomes on survival. Hepato Pancreato Biliary 2016, 18: e171. DOI: 10.1016/j.hpb.2016.02.408.Peer-Reviewed Original Research